... This news release is available in a onClick NewPopupWindow(t...In Parkinson's disease the protein alpha-synuclein aggregates and a...Parkinson's disease is a disorder of the nervous system. It typically ...At the present no cure exists for Parkinson's disease although sympt...

In Parkinson's disease, the protein "alpha-synuclein" aggregates and accumulates within neurons. Specific areas of the brain become progressively affected as the disease develops and advances. The mechanism underlying this pathological progression is poorly understood but could result from spreading of the protein (or abnormal forms of it) along nerve projections connecting lower to upper brain regions. Scientists at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have developed a novel experimental model that reproduces for the first time this pattern of alpha-synuclein brain spreading and provides important clues on the mechanisms underlying this pathological process. They triggered the production of human alpha-synuclein in the lower rat brain and were able to trace the spreading of this protein toward higher brain regions. The new experimental paradigm could promote the development of ways to halt or slow down disease development in humans. The research team headed by Prof. Donato Di Monte presents these results in the scientific journal "EMBO Molecular Medicine".

Parkinson's disease is a disorder of the nervous system. It typically manifests itself with motor disturbances, such as an uncontrollable trembling of the limbs, as well as non-motor symptoms, including sleep disorders and depression.

At the present, no cure exists for Parkinson's disease, although symptomatic intervention, including treatment with dopamine agonists, can alleviate patients' motor impairment. Parkinson's is the second most common neurodegenerative disorder, after Alzheimer's disease; it is estimated that 100,000 to 300,000 patients are affected by Parkinson's disease in Germany alone.

(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way ... when it comes time to cook the next meal, making July the most appropriate ... practicing best grilling tips and recipes. , Make the next cookout different than the ...

(Date:7/31/2015)... ... ... According to the article published July 27 on My News LA, a fire ... by the city’s fire department before it caused major damage throughout the building. The article ... and it was a fire alarm system that tipped off fire fighters so they could ...

... Leventhal, Esq., the Founder and President of Leventhal Consulting, ... weight loss consulting service for attorneys by an attorney, ... at 11:45 am today at Hellriegel,s Inn, 1840 Mentor ... one-on-one personalized approach, and works with clients over the ...

... New program rewards employees for physical activity and ... of Dalbey Education, headquartered in Westminster, CO, can ... getting healthy through the company,s new health and ... company Humana Inc., the program incentivizes and rewards ...

... (BUSM) has received an initial grant of $260,000 from the ... Yerevan State Medical University (YSMU) in Armenia. The project ... comparable to that in the US and Western Europe. ... a model and modify it as appropriate for Armenian students. ...

... 25 Orthopaedic surgeon John J. Callaghan, MD was elected ... of Orthopaedic Surgeons ( http://www.aaos.org/ )(AAOS) at the organization,s ... the Academy as First Vice-President.Having to wear a cast as ... to go into the field of orthopaedic surgery. "Breaking ...

(Date:7/30/2015)... VANCOUVER , July 30, 2015 OncoGenex Pharmaceuticals, ... will report its second quarter 2015 financial results on ... conference call and live webcast at 4:30 p.m. Eastern ... development programs and a general corporate update. ... Investor Relations page of the OncoGenex website at ...

(Date:7/30/2015)... FALLS, Ohio , July 30, 2015 Cleveland ... his OMTEC® 2015 keynote address last month that industry ... models in order to gain the efficiencies—and develop the ... Dr. Barsoum,s comments were preceded by ... avid entrepreneur and OMTEC moderator, who stressed that industry ...

... DIEGO, Nov. 16, 2010 Cylene Pharmaceuticals, Inc. will ... inhibitor CX-4945, at the 22nd EORTC-NCI-AACR symposium on Molecular ... 16-19 in Berlin, Germany. CX-4945 is the first and ... represents an exciting new approach for the treatment for ...